These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14986777)

  • 21. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases.
    Ellenberg SS; Temple R
    Ann Intern Med; 2000 Sep; 133(6):464-70. PubMed ID: 10975965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Controversies over the surgical placebo: legal issues and the ethical debate].
    Hervé C; Moutel G; Meningaud JP; Wolf M; Lopes M
    Presse Med; 2000 Jun; 29(21):1180-3. PubMed ID: 10906941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Placebo in Pediatric Inflammatory Bowel Diseases: A Position Paper From ESPGHAN, ECCO, PIBDnet, and the Canadian Children IBD Network.
    Turner D; Koletzko S; Griffiths AM; Hyams J; Dubinsky M; de Ridder L; Escher J; Lionetti P; Cucchiara S; Lentze MJ; Koletzko B; van Rheenen P; Russell RK; Mack D; Veereman G; Vermeire S; Ruemmele F
    J Pediatr Gastroenterol Nutr; 2016 Jan; 62(1):183-7. PubMed ID: 26545204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is the use of placebo controls ethically permissible in clinical trials of agents intended to reduce fractures in osteoporosis?
    Brody BA; Dickey N; Ellenberg SS; Heaney RP; Levine RJ; O'Brien RL; Purtilo RB; Weijer C
    J Bone Miner Res; 2003 Jun; 18(6):1105-9. PubMed ID: 12817764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethical Overview of Placebo Control in Psychiatric Research - Concepts and Challenges.
    Ćurković M; Živković M; Radić K; Vilibić M; Ćelić I; Bagarić D
    Psychiatr Danub; 2015 Jun; 27(2):118-25. PubMed ID: 26057306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attitudes toward placebo-controlled clinical trials among depressed patients in Japan.
    Sugawara N; Ishioka M; Tsuchimine S; Tsuruga K; Sato Y; Tarakita N; Furukori H; Kudo S; Tomita T; Nakagami T; Yasui-Furukori N
    J Affect Disord; 2018 Jan; 225():313-316. PubMed ID: 28843082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Informed consent and the use of placebo in Poland: ethical and legal aspects.
    Zaborowski P; Górski A
    Sci Eng Ethics; 2004 Jan; 10(1):167-78. PubMed ID: 14986783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physicians' preferences for active-controlled versus placebo-controlled trials of new antihypertensive drugs.
    Halpern SD; Ubel PA; Berlin JA; Townsend RR; Asch DA
    J Gen Intern Med; 2002 Sep; 17(9):689-95. PubMed ID: 12220365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scientific and ethical issues in the use of placebo and active controls in clinical trials.
    Ellenberg SS
    J Bone Miner Res; 2003 Jun; 18(6):1121-4. PubMed ID: 12817767
    [No Abstract]   [Full Text] [Related]  

  • 31. Consensus-seeking roundtable on placebos in clinical research.
    Weijer C
    NCEHR Commun; 1998-1999 Fall; 9(1):6-9. PubMed ID: 15468464
    [No Abstract]   [Full Text] [Related]  

  • 32. The placebo problem remains.
    Michels KB
    Arch Gen Psychiatry; 2000 Apr; 57(4):321-2. PubMed ID: 10768689
    [No Abstract]   [Full Text] [Related]  

  • 33. Safety of placebo controls in pediatric hypertension trials.
    Smith PB; Li JS; Murphy MD; Califf RM; Benjamin DK
    Hypertension; 2008 Apr; 51(4):829-33. PubMed ID: 18285612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ethical implications of placebo-controlled clinical trials for psychotropic drugs].
    Helmchen H
    Nervenarzt; 2005 Nov; 76(11):1319-29. PubMed ID: 15812676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues.
    Temple R; Ellenberg SS
    Ann Intern Med; 2000 Sep; 133(6):455-63. PubMed ID: 10975964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Public attitudes regarding willingness to participate in medical research studies.
    Trauth JM; Musa D; Siminoff L; Jewell IK; Ricci E
    J Health Soc Policy; 2000; 12(2):23-43. PubMed ID: 11184441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Declaration of Helsinki and clinical trials: a focus on placebo-controlled trials in schizophrenia.
    Carpenter WT; Appelbaum PS; Levine RJ
    Am J Psychiatry; 2003 Feb; 160(2):356-62. PubMed ID: 12562584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethical considerations concerning treatment allocation in drug development trials.
    Senn S
    Stat Methods Med Res; 2002 Oct; 11(5):403-11. PubMed ID: 12357586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Debate about placebos points to issue surrounded by many shades of grey.
    Baer N
    CMAJ; 1996 Nov; 155(10):1475-6. PubMed ID: 8943938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.